Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Joshua Fineman - Ascendis Pharma gains amid takeover speculation (ASND:NASDAQ)
Ascendis Pharma gains amid takeover speculation (ASND:NASDAQ)
Seeking Alpha

Ascendis Pharma (ASND) ADRs quickly rose 8% amid some takeover speculation. There's speculation that the Danish pharmaceutical firm may have attracted takeover interest. It's not clear who is interested in the company. Ascendis (ASND) has a market…

zerohedge.com - Tyler Durden - Lefty 'Consumer' Watchdog Group Bought & Paid For By Big Pharma
Lefty 'Consumer' Watchdog Group Bought & Paid For By Big Pharma
Zero Hedge

The National Consumers League is America's oldest consumer advocacy organization and a group trusted by the left, especially, to stand up for consumers' interests. But according to a review of its tax filings by the Washington Examiner, it has also…

thehindu.com - Ramya Kannan - Pharma major Dr. Reddy's to produce and market drug for gonorrhoea granted approval by U.S. FDA
Pharma major Dr. Reddy's to produce and market drug for gonorrhoea granted approval by U.S. FDA
The Hindu

The U.S. Food and Drug Administration (FDA) has granted approval for two new oral medicines to treat gonorrhoea, a common sexually transmitted infection, prone to resistance against drugs. Indian pharma major Dr. Reddy's is taking steps to obtain…

marketbeat.com - Eventide Asset Management LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO
Eventide Asset Management LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Eventide Asset Management LLC cut its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 27.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund…

marketbeat.com - Eventide Asset Management LLC Buys 41,830 Shares of Royalty Pharma PLC $RPRX
Eventide Asset Management LLC Buys 41,830 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Eventide Asset Management LLC boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 921,639…

marketbeat.com - Gilder Gagnon Howe & Co. LLC Boosts Stake in BridgeBio Pharma, Inc. $BBIO
Gilder Gagnon Howe & Co. LLC Boosts Stake in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Gilder Gagnon Howe & Co. LLC grew its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 280.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Volume Increase - Here's Why
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Volume Increase - Here's Why
MarketBeat

Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) saw an uptick in trading volume on Thursday. 1,614 shares changed hands during trading, an increase of 114% from the previous session's volume of 755 shares.The stock last traded at…

investors.com - PAOLO CONFINO - Eli Lilly Leads 5 Stocks Near Buy Points In Divided Market
Eli Lilly Leads 5 Stocks Near Buy Points In Divided Market
Investor's Business Daily

Pharma companies, airlines, mining companies, and retailers all benefited from the rotation out of tech that happened over the course of last week. Household names like Eli Lilly, Urban Outfitters, and United Airlines lead this diversified set of…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Unusually-High Trading Volume - What's Next?
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Unusually-High Trading Volume - What's Next?
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares saw strong trading volume on Thursday. 1,614 shares were traded during mid-day trading, an increase of 114% from the previous session's volume of 755 shares.The stock last traded at $79.86…

rediff.com - Sanket Koul - 14+ Anti-Obesity Drugs In The Pipeline
14+ Anti-Obesity Drugs In The Pipeline
Rediff.com

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. Danish drugmaker Novo Nordisk has launched its semaglutide-based diabetes therapy…

republicworld.com - Nitin Waghela - India's Biggest 100 Wealth Creators: Did You Bet On These Stock Picks In 2025?
India's Biggest 100 Wealth Creators: Did You Bet On These Stock Picks In 2025?
Republic World

India's top 100 wealth creators clocked in Rs 148 trillion between 2020 and 2025, led by large cap firms from several sectors, including ICICI Bank and Bharti Airtel. The telecom giant Bharti Airtel became the biggest wealth creator, garnering Rs…

dailymail.co.uk - Maureen Callahan - Scandalous truth about Ariana Grande and what Ozempic is really doing
Scandalous truth about Ariana Grande and what Ozempic is really doing
Mail Online

It's not just Ariana, or Amy, or Kelly and Oprah — it's the era of the medically endorsed eating disorder. The Ozempic craze is killing us. It's a plague, and anyone not on it is made to feel as if they're the insane ones. Take Ariana…

marketbeat.com - Best Growth Stocks Worth Watching - December 12th
Best Growth Stocks Worth Watching - December 12th
MarketBeat

Constellation Brands: A Fallen Star or a Hidden Value Play? Canopy Growth, Prologis, Ascendis Pharma A/S, Teledyne Technologies, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth…

marketbeat.com - Twist Bioscience Corporation $TWST Stock Holdings Lifted by EdgePoint Investment Group Inc.
Twist Bioscience Corporation $TWST Stock Holdings Lifted by EdgePoint Investment Group Inc.
MarketBeat

EdgePoint Investment Group Inc. lifted its holdings in shares of Twist Bioscience Corporation (NASDAQ:TWST - Free Report) by 114.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission.

fool.com - Adria Cimino - My Top 10 Stocks to Buy for 2026
My Top 10 Stocks to Buy for 2026
The Motley Fool

Overall, the past three years have been positive for investors, with the S&P 500 bull market going strong. The famous benchmark advanced more than 20% in each of the past two years, and today it's heading for yet another double-digit annual gain.

Receive a Daily briefing on Pharma Industry News

Get Started